13 Jun 2019

DO YOUR OLDER PATIENTS REGARD THEIR HEALTH AS GOOD OR POOR?

    By Judith Graham A common myth about aging is that older adults are burdened by illness and feel lousy much of the time. In fact, the opposite is usually true. Most seniors report feeling distinctly positive about their health. Consider data from the 2017 National Health Interview Survey (the most

0
12 Jun 2019

VICI VENOUS STENT: FDA OKs VICI Venous Stent to treat Iliofemoral obstructive disease

    The U.S Food and Drug Administration has approved Boston Scientific’s VICI Venous Stent System for the treatment of iliofemoral venous obstructive disease, which occurs when the flow of blood through the veins located deep in the pelvic region becomes blocked by a blood clot or compressed by anatomical anomalies.

0
12 Jun 2019

VECLOSE EXTENSION STUDY: Five-year outcomes prove durability, safety, efficacy of VenaSeal Closure System

    By Larry Storer Five-year results from the 2019 VeClose Extension Study of the Medtronic VenaSeal Closure System demonstrate that the treatment modality is consistent, durable and safe for permanently closing veins in patients with venous reflux disease. When compared with Medtronic Radiofrequency Ablation, VenaSeal continued to show “non-inferiority”

0
12 Jun 2019

MERZ REGAINS SOLE DISTRIBUTION OF ASCLERA FROM ANGIODYNAMICS

  Merz North America Inc. has regained exclusive distribution of Asclera (polidocanol) Injection in the United States to all healthcare practitioners and phlebologists treating varicose veins. Also effective April 8, AngioDynamics Inc. is no longer an authorized distributor of Asclera. All HCPs will now be able to purchase Asclera directly

0
12 Jun 2019

NEVER SAY DIE: WHY MOST DOCTORS WON’T BREAK BAD NEWS

  By JoNel Aleccia After nearly 40 years as an internist, Portland, Oregon physician Ron Naito knew what the sky-high results of his blood test meant. And it wasn’t good. But when he turned to his doctors last summer to confirm the dire diagnosis — stage 4 pancreatic cancer —

0
24 May 2019

USE OF BUPRENORPHINE TO TREAT OPIOID ADDICTION PROLIFERATES IN CALIFORNIA

By Harriet Blair Rowan Buprenorphine, a relative newcomer in the treatment of opioid addiction, is growing in popularity among California doctors as regulatory changes, physician training and other initiatives make the medication more widely accessible. The rate of Medi-Cal enrollees who received buprenorphine nearly quadrupled from the end of 2014 to

0
24 May 2019

ANALYSIS: A HEALTH CARE OVERHAUL COULD KILL 2 MILLION JOBS, AND THAT’S OK

By Elisabeth Rosenthal As calls for radical health reform grow louder, many on the right, in the center and in the healthcare industry are arguing that proposals like “Medicare for All” would cause economic ruin, decimating a sector that represents nearly 20% of our economy. While exploring a presidential run,

0
21 May 2019

HIDDEN FDA REPORTS MASKED THE SCOPE OF WIDESPREAD HARM FROM FAULTY HEART DEVICE

By Christina Jewett Faced with the possibility that a bout of abnormal heartbeats could end his life, in 2006, Dr. Marc Sicklick had a small device implanted in his chest that would shock it back into rhythm. Soon he would struggle with another life-or-death choice: whether to remove the Sprint Fidelis,

0
09 May 2019

3D printing innovation allows scientists to create vascular network

  By Jade Boyd Bioengineers have cleared a major hurdle on the path to 3D printing replacement organs with a breakthrough technique for bioprinting tissues. The new innovation allows scientists to create exquisitely entangled vascular networks that mimic the body’s natural passageways for blood, air, lymph and other vital fluids.

0
08 May 2019

DRUG INDUSTRY PATENTS GO UNDER SENATE JUDICIARY COMMITTEE’S MICROSCOPE

By Rachel Bluth   Congress isn’t making much headway in finding a solution to the problem of soaring prescription drug prices, but lawmakers from both parties are tinkering on the edges with legislation that aims to increase competition among drugmakers. A comprehensive piece of drug-pricing legislation is a high priority for

0